Mark Bowden
Family Medicine · Brooksville, FLNPI 1669580668
Payments from drug & device makers
Across 221 payments — averaging $16.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$637
- GSK$485
- Novo Nordisk$470
- Amarin Pharma, Inc.$281
- Lilly USA, LLC$209
- Boehringer Ingelheim$207
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,742100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 40 | $637 |
| GSK | 31 | $485 |
| Novo Nordisk | 27 | $470 |
| Amarin Pharma, Inc. | 13 | $281 |
| Lilly USA, LLC | 14 | $209 |
| Boehringer Ingelheim | 12 | $207 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $156 |
| Amgen(2 entities) | 9 | $153 |
| Merck | 7 | $108 |
| Eisai Inc. | 7 | $106 |
| Sanofi-aventis U.S. LLC | 6 | $105 |
| Abbott | 6 | $104 |
| Pfizer | 6 | $95 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $80 |
| AbbVie | 4 | $79 |
| Astellas Pharma US Inc | 3 | $57 |
| Novartis | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Johnson & Johnson | 3 | $44 |
| Idorsia Pharmaceuticals US Inc | 2 | $40 |
| Mylan Specialty L.p. | 2 | $35 |
| Biohaven Pharmaceuticals, Inc. | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Protega Pharmaceutials Inc | 1 | $25 |
| Dexcom, Inc. | 1 | $23 |
| Exact Sciences | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Fidia Pharma USA Inc. | 1 | $12 |
How this compares
$3,754 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 31 | $23,789 |
| JardianceEmpagliflozin | 24 | $23,430 |
| EliquisApixaban | 21 | $21,306 |
| FarxigaDapagliflozin Propanediol | 13 | $12,559 |
| MounjaroTirzepatide | 11 | $11,263 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 11 | $4,767 |
| VascepaIcosapent Ethyl | 12 | $4,285 |
| Fentanyl | 21 | $2,548 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 64 | $1,631 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $1,500 |
| Alprazolam | 101 | $1,311 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 39 | $1,055 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $1,046 |
| Oxycodone Hcl | 42 | $891 |
| Ventolin HfaAlbuterol Sulfate | 12 | $764 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $485 | $23,78931 claims |
| Boehringer IngelheimJardiance | $207 | $23,43024 claims |
| PfizerEliquis | $95 | $21,30621 claims |
| AstraZenecaFarxiga, Bevespi Aerosphere | $637 | $17,32624 claims |
| Lilly USA, LLCMounjaro | $209 | $11,26311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Brooksville
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.